Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

GSK PLC GSK shares inched up 0.03% to £14.97 Thursday, on what proved to be an all-around favorable trading session for the ...

Check the time stamp on this data. Updated AI-Generated Signals for Gsk Plc American Depositary Shares (each Representing Two ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University ...

A decision to relocate a town's library has been upheld despite a consultation into the plans being labelled unfair and not ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...

GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...

The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...